Cost of recently approved biotech therapies
Drug | Used to treat | Annual cost |
---|---|---|
Omalizumab (Xolair) | Allergic asthma | $15,0001 |
Enfuvirtide (Fuzeon) | Advanced HIV | $20,0001 |
Cetuximab (Erbitux) | Colon cancer | $120,0002 |
Laronidase (Aldurazyme) | MPS-1, genetic enzyme deficiency | $170,0001 |
MPS=MUCOPOLYSACCHARIDOSIS
CAREMARK RX TRENDS REPORT 2003
MEDCO HEALTH SOLUTIONS VIA BALTIMORE SUN